Laboratory Services Division
Universal and routine access to quality assured HIV related laboratory services are made available through the activities of Laboratory Services Division. It is recognized that work related to laboratory services are not confined to HIV testing, but are overarching and have an impact on other interventions included under prevention, care, support and treatment, STI management, blood safety, procurement and supply chain management. Emphasis on quality assured laboratory service delivery is important to the success of NACP.
To ensure quality of HIV testing under the NACP, NACO has an External Quality Assessment Programme administered to all HIV testing laboratories. The HIV testing laboratories are arranged in a tiered manner with apex laboratory (NARI, Pun) at the very top. 13 National Reference Laboratories (NRLs) and 117 State Reference Laboratories (SRLs) form the two subsequent tiers of the laboratory framework and are involved in supervision of testing in all peripheral testing centers (ICTCs).
The testing activities of 272 CD4 testing laboratories, 6 laboratories for testing under EID Programme and 10 Viral Load Testing Laboratories under the NACO umbrella are supervised by the Laboratory Services Division
Major activities of Laboratory Services Division:
- Framing guidelines for HIV testing, Quality in HIV Testing, Enumeration of T lymphocytes and Laboratory guidelines for Early Infant Diagnosis
- Accreditation of HIV testing Laboratories.
- Establishing and improving Quality Management Systems in CD4 testing laboratories, STI laboratories and ICTCs.
- External Quality Assurance Programme for HIV testing laboratories
- Consortium for ensuring kit Quality in NACP
- Testing Services in National Programme on Early Infant/child less than 18 months Diagnosis.
- CD4 testing for initiation and monitoring of patients on antiretroviral therapy (ART)
- Viral Load testing for second line ART
- Training of laboratory personnel.
|Laboratory Services Division||Details|
|Oscar Medicare DHR2212046||Details|
|Consortium Quarterly Report July December 2022||Details|
|Oscar Medicare DHR2212047||Details|
|Kit Evaluation Report Meriscreen MI032239||Details|
|Kit Evaluation Report Meriscreen MI032228||Details|
|Proficiency testing provider Unit||Details|
|Consortium Of NRLs For Kit Quality||Details|
|Quarterly report of kits evaluated under Consortium, July-Sept, 2017||Details|
|Quarterly report of kits evaluated under Consortium, Apr-June, 2017||Details|
|Quarterly report of kits evaluated under Consortium, Jan-Mar, 2017||Details|
|Quarterly report of kits evaluated under Consortium, Oct - Dec 2016||Details|
|Quarterly report of kits evaluated under Consortium, July - Sept 2016||Details|
|Quarterly report of kits evaluated under Consortium, April-June 2016||Details||Quarterly report of kits evaluated under Consortium, Jan - Mar 2016||Details|
|List of NABL accredited HIV Reference labs (as on 31/12/2017)||Details|
|List of CD4 accreditation Status (as on 31/12/2017)||Details|
|List of Technical Resource Group||Details|
|List of EID and Viral load labs (Date Uploaded: 02/09/2016)||EID.pdf |
|Lab Services Technical Specifications, Publications||Details|
|Lab Services Policies & Guidelines||Details|
|Retention of documents records pertaining to Testing & Reporting of HIV AIDS||Details|
|HIV testing kits -approved batch numbers-2015||Details|
|List of CD4 Machines (Date Uploaded: 02/09/2016)||Details|